BiotechTube
Home/RevolKa/Mitsuo Umetsu, Ph.D.
MU

Mitsuo Umetsu, Ph.D.

Chief Scientific Officer

RevolKa

Therapeutic Areas

Rare Diseases

RevolKa Pipeline

DrugIndicationPhase
Rare Disease Drug Discovery ProgramUndisclosed Rare DiseasesPreclinical

Leadership Team at RevolKa

NH
Norio Hamamatsu, Ph.D.
President and CEO
View full RevolKa profile